India’s Cipla defeated the profit view of the third quarter, because strong domestic demand offset the weak sales in the United States
2025-01-28 16:25:00 : Author Rishika Sadam and Kashish Tandon Haidraba/Bangalore (Reuters) -Cipla is one of the largest pharmaceutical manufacturers in India and has the largest sales. It reported on Tuesday the third quarter profit that exceeded expected, which is helpful to the strong domestic demand. Frozen assistance to certain drug plans will not damage some … Read more